28/02/2013 02:15:00

EADS Chief Leaves Door Ajar for Another BAE Try

Related content

The chief executive of European Aeronautic Defense & Space Co. (EAD.FR) has left the door ajar for the revival of a blockbuster merger with BAE Systems PLC (BA.LN), the Times in London reported on its website Thursday.

Tom Enders, the German head of the Airbus manufacturer, said that a decision on EADS's ambitions to expand its defense interests--potentially in a tie-up with BAE--would be made after the completion of a strategic review of its military business and the shake-up of the group's board this spring, the Times said. Any new move, he indicated, wasn't imminent, the Times said.

The two companies abandoned a prior try at a merger.

Write to Dennis Baker at dennis.baker@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

February 27, 2013 21:15 ET (02:15 GMT)

Copyright (c) 2013 Dow Jones & Company, Inc.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

Tech Companies Send Criticism Along With NSA-Related Data -- Update

04/02/2014 00:06:00
By Danny Yadron Technology companies including Google Inc. and Microsoft Corp. released new figures on the amount of data requests they received from U.S. ..

U.S. Hot Stocks: Hot Stocks to Watch

03/02/2014 14:07:00
Among the companies with shares expected to actively trade in Monday's session is Herbalife Ltd. (HLF). Herbalife Ltd. (HLF) raised its fourth-quarter outl..

Pfizer Study Meets Primary Endpoints

03/02/2014 13:05:00
Pfizer Inc. (PFE) said Monday that a Phase 2 trial of its advanced breast cancer treatment met its primary endpoint. Pfizer said a study comparing the effec..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Novartis Bexsero® vaccine approved by FDA for the prevention of meningitis B, the leading cause of bacterial meningitis in the US
2
Sika AG: FAMILY LOSES VOTING RIGHTS PRIVILEGE - 35% OF SHAREHOLDERS SUPPORT BOARD OF DIRECTORS' COURSE
3
ATARI : US$ 7.6 million in consolidated revenues at December 31, 2014, up from US$ 2.3 million the previous year
4
YIT adjusts its operations in Russia
5
Sanofi : Sanofi and Regeneron Announce Praluent(TM) (alirocumab) Biologics License Application has Been Accepted for Priority Review by US FDA

Related stock quotes

BAE Systems PLC ORD 2.5P 515.00 -0.8% Stock price decreasing

Buy and sell signals

  • Trend
  • Moneymachine

Related companies
Get access to information and recommendations of related companies with our PLUS package.

You get access to 7 valuable investment tools.

Click here to read more about the PLUS package.

Copyright Euroinvestor A/S 2015   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
26 January 2015 10:21:06
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20150121.1 - EUROWEB6 - 2015-01-26 11:21:06 - 2015-01-26 10:21:06 - 1000 - Website: OKAY